Atzeyo Biosensors, Inc.

Attending the Chicago Biomedical Consortium’s BioCapital Summit on November 7th? Join us and meet the Atzeyo Biosensors team! We're pioneering advancements that change the cancer patient journey through early, accessible, and accurate diagnostics. Come by to explore our cutting-edge biosensing technology and learn how we're transforming cancer detection and patient care. ?? November 7th, 2024 ?? Chicago Biomedical Consortium BioCapital Summit We look forward to connecting with industry leaders and innovators passionate about revolutionizing healthcare!

Atzeyo Biosensors, Inc.’s Co-Founder,?Dr.Brian Cunningham, was recently interviewed by?WCIA 3 (Champaign)?to discuss his team’s development of cutting-edge technology aimed at improving cancer detection and treatment. The?Photonic Resonator Absorption Microscopy (PRAM)?system, designed by Dr. Cunningham’s lab uses LED illumination of a sensor for digital counting of detected molecules with an inexpensive webcam-quality image sensor to send results to a wirelessly linked mobile device. This technology is targeted for the doctor’s office to enable faster cancer detection and determination of the most effective treatment option Dr. Cunningham’s dedication to improving cancer treatment is deeply personal, stemming from the loss of his father to aggressive prostate cancer. His mission is to make cancer treatment more effective and accessible, particularly in regions with limited access to advanced medical care. Although still in development, this technology holds great promise for expanding access to life-saving diagnostics. Read the full interview to learn more- https://lnkd.in/d3dfxVxT #CancerResearch #HealthTech #Biosensing #PRAM #PointOfCare #MedicalInnovation #Atzeyo #HealthcareSolutions

Dr. Brian Cunningham Showcased at UIUC Founder’s Week! At?UIUC Founder’s Week, Atzeyo Biosensors, Inc.’s Co-Founder?Dr. Brian Cunningham?participated in a fireside chat?alongside?Prof. Brooke Elliott?(Dean of the Gies College of Business) and?Prof. Susan Martinis?(Vice Chancellor for Innovation and Research at UIUC).? The panel focused on collaboration between engineering, like Dr. Cunningham’s work on?portable biosensing technology, with business-oriented individuals to foster innovation. The work pioneered by Dr. Cunningham's lab is foundational to Atzeyo Biosensors, Inc.'s diagnostic product platforms and brings precision care directly to the point of need, enhancing patient outcomes by improving access in remote and underserved areas. Stay tuned for more exciting updates as we continue pushing the boundaries of health innovation with our latest product developments. #Innovation #HealthTech #Biosensing #PointOfCare #Entrepreneurship #Founder’sWeek #AtzeyoBiosensors [ https://lnkd.in/gARCCwau ]

We’re proud to share that Atzeyo Biosensors, Inc. co-founder Dr. Brian Cunningham at the Cancer Center at Illinois (CCIL) has developed two powerful diagnostic tools—the ap-PRAM and PRAM Mini. The ap-PRAM and PRAM Mini utilize novel technology enabling faster and more precise detection of cancer biomarkers, which has been a much-needed improvement to point-of-care diagnostics, enabling faster and more precise detection of cancer biomarkers. With a focus on affordability and ease of use, these devices could significantly improve patient outcomes.? Learn more about this groundbreaking work! Link: https://lnkd.in/grEs2ZDV

Attending the?SelectBIO Conference on Emerging Technologies for Point of Care Diagnostics and Liquid Biopsies?in New Orleans this Thursday and Friday? Check out the keynote presentation by Atzeyo co-founder Dr. Brian Cunningham ???Session Title:?Circulating Biomarkers and Technologies for Interrogation ???Time:?14:00 ???Venue:?Fleur De Lis Ballroom His keynote presentation, titled: "Rapid and Ultrasensitive Point of Care Digital Resolution Diagnostics using Nucleic Acid Engineering and Photonic Crystals,"?will cover innovative technology platforms designed to advance diagnostic testing for viral pathogens and cancer biomarkers. Dr. Cunningham,?Professor and Intel Alumni Endowed Chair at the University of Illinois at Urbana-Champaign, will discuss the groundbreaking efforts at the Center for Genomic Diagnostics to overcome the limitations of traditional laboratory-based nucleic acid testing. His team’s research leverages?Photonic Crystal nanostructured surfaces?to enable digital, single-unit detection of molecules and viruses, eliminating the need for complex workflows, expensive equipment, or enzymatic amplification. Key topics of presentation include: - Amplification of fluorescence and scattering to use simple, inexpensive detection instruments. - Innovative DNA nanostructures that recognize and capture viruses for digital counting. - A novel application of?CRISPR/Cas technology?for detecting circulating tumor DNA without PCR pre-amplification. This presentation will showcase recent results and the vision for diagnostic approaches in clinics and specialty physician offices. For more details, check out the conference agenda here: https://lnkd.in/dedN5Vbx #pointofcare #diagnostics #liquidbiopsy #nucleicacidengineering #photoniccrystals #CRISPR #biotechnology #innovation #NewOrleans

Exciting news from Atzeyo Biosensors, Inc.! We’re thrilled to share the latest publication by our co-founder, Brian Cunningham, in?Biomedical Optics Express. The study, titled “Portable, smartphone-linked and miniaturized photonic resonator absorption microscope (PRAM Mini) for point-of-care diagnostics,” highlights groundbreaking advancements in compact diagnostic technology. The PRAM Mini is a game-changer for point-of-care diagnostics, offering real-time, precise detection of biomarkers using gold nanoparticles (AuNPs) with sensitivity down to a single molecule. This innovation simplifies testing by enabling on-site diagnostics without the need for costly, centralized lab equipment. In the study, the PRAM Mini demonstrated its ability to detect anti-SARS-CoV-2 antibodies in cat serum samples, with remarkable sensitivity and a 15-minute assay time. The compact design, smartphone integration, and cost-effectiveness make it a promising tool for enhancing healthcare accessibility and patient care. Beyond healthcare, PRAM Mini’s affordability and portability open doors to use cases in veterinary clinics, environmental monitoring, and even food safety. ?Learn more about this cutting-edge tool and its potential to transform diagnostics: https://lnkd.in/ddiDUx96

We are excited to share the latest paper from Atzeyo co-founder Brian Cunningham! Published in Biosensors and Bioelectronics journal, the study demonstrates significant advancements in the automation of the biosensor-based PRAM platform. This new system integrates computer-controlled motorized translation stages and time-series image collection, enabling rapid and precise biomarker detection. The ability of the ap-PRAM to digitally count the arrival and departure of gold nanoparticles (AuNPs) with single-molecule precision, makes it a powerful tool for dynamic analysis of biomolecular interactions. This study demonstrates that the ap-PRAM system can track biomolecular interactions?in real-time?in viral antibody detection and cancer-associated miRNA biomarkers. We are one step closer to bringing a high-sensitivity molecular detection platform to the physician’s office! Take a deeper dive into this groundbreaking work. https://lnkd.in/gugrNMKX